SEVERAL general accounts of the biochemistry of the myopathies have recently appeared (e.g. Schapira and Dreyfus, 1963; Pennington, 1964 Most of this article will be devoted to a discussion of these topics, but to provide the necessary biochemical background it is necessary to deal briefly with some of the less specific biochemical changes that occur.
Changes in Creatine and Creatinine

Metabolism
It has been realised for more than 50 years that some muscle disorders are accompanied by an increased urinary output of creatine (Levene and Kriszteller, 1909 ) and a decreased output of its anhydride creatinine.
It has been shown that creatine is stored in the muscle as creatine phosphate but is synthesised elsewhere. Production of creatine phosphate is mediated by the enzyme creatineadenosine triphosphate phosphotransferase, an enzyme, subsequently referred to by its trivial name, phosphocreatine kinase, which catalyses the following reaction: Creatine + ATP , Creatine phosphate + ADP the so-called Lohman reaction (Lohman, 1934) .
Creatine is formed by the breakdown, probably spontaneous, of creatine phosphate. When muscle degeneration occurs, capacity to store creatine as the phosphate is reduced, whereas normally the rate of synthesis is maintained. The resultant creatinaemia provokes a creatinuria when the renal threshold of this substance is exceeded. On the other hand, since creatinine is formed from creatine phosphate the urinary output of creatinine falls. Because the creatinuria is chiefly a result of reduced muscle mass, it is a pretty non-specific accompaniment of muscle wasting and of little help in diagnosis; thus Van Pilsum and Wolin (1958) found a marked creatinuria both in pseudohypertrophic muscular dystrophy and in poliomyelitis. Before leaving the topic of creatine metabolism it may be noted that reversibility of the phosphocreatine kinase reaction provides a means by which ATP can be resynthesised from creatine phosphate. As (Slater, 1960 (Stein and Padykula, 1962 , although Ronzoni and others (1960) . This is rather surprising in view of the fact that electron microscope studies (e.g. Van Breemen, 1960; Pearce, 1963) (Wieme, 1959) , and which may also be distinguished by differences in their enzymic behaviour (Plummer, Elliott, Cooke and Wilkinson, 1963; Dawson, Goodfriend and Kaplan, 1964 (1962) suggested that this indicates a failure of maturation. However other workers (Lauryssens and others, 1963; Brody, 1964) have found similar abnormalities in human neurogenic atrophy as well as in primary muscle disease, and Brody (1964) has demonstrated a progressive change following experimental denervation in the guinea pig. Dawson and others (1964) (1964) have shown considerable differences between normal muscles in their content of the various types of lactate dehydrogenase.
Other Abnormalities
In addition to the topics mentioned above numerous other biochemical abnormalities have been described in diseased muscle, some perhaps of very considerable importance for understanding the degenerative process, an example 'being the marked increase of various hydrolytic enzymes. Nevertheless since many of these are discussed in the reviews cited already, they will not be considered further.
However one recent observation of considerable interest has been described by Watts and Hooton (1965) who found that a purified phosphocreatine kinase derived from dystrophic mice, despite having the same electrophoretic properties as the enzyme from normal animals, was only half as active. Phosphocreatine kinase possesses two sulphydryl groups (-SH) in the molecule which are concerned with activity and, as a possible explanation for their results, these authors suggested that one of the -SH groups might be inactivated in vivo. Since a number of enzymes, including myosin ATPase, require intact sulphydryl groups for activity, any increased tendency towards SH inactivation might have profound metabolic consequences, and it will be of great interest to see if future work confirms such a possibility in the mouse disease and in human myopathies. Familial Periodic Paralysis Recent accounts of the biochemical changes found in both hypo-and hyperkalemic familial periodic paralysis have been given by McArdle (1964) and by Pearson (1964) , so that these biochemically interesting conditions will not be discussed here. (Schmid and Mahler, 1959; Schmid and Hamaker, 1961; Rowland and others, 1963) , and the late development of a limb girdle myopathy (Schmid and Mahler, 1959; Schmid and Hamaker, 1961 (Opie, Evans and Renold, 1962; Wolf, 1962) . Despite the theoretical possibility of resultant increased glycogen deposition in the muscle it has been proposed that patients should take oral fructose prior to unavoidable exertion (Mellick and others, 1962; McArdle, 1964) , but this does not always seem to be effective (Hockaday and others, 1964) . (1962) reported that there was a statistically significant difference between the mean serum activities for normal men and women. This difference has not however been substantiated by other authors. Thus although Griffiths (1964) reports a rather higher mean activity for male children and adults, as compared with females, the differences were smaller and not statistically significant. Pearce, Pen- Hughes (1963b) nington and Walton (1964a) Schlang, 1961; Halonen and Konttinen, 1962 ) the rise being greater in untrained as compared with trained subjects (Fowler, Chowdbury, Pearson, Gardner and Bratton, 1962) . If a substantial rise occurs after moderate exercise then obviously care needs to be taken when interpreting results obtained on uncontrolled subjects. Richterich, Rosin, Aebi and Rossi (1963) have reported that a marked rise of phosphocreatine kinase may also occur after exercise, but Hughes (1963a) (Dubowitz, 1960; Walton, 1962) . In this form of the disease an extremely high percentage of patients show grossly elevated serum phosphocreatine kinase activities which in young patients may be more than 100 times the upper limit of normal (e.g. Hughes, 1963b; Pearce, Walton and Pennington, 1964b) . Moreover in a number of cases elevated values have been observed in children before clinical signs of muscle disease had become apparent (Fowler and Pearson, 1964) . The serum level falls as the disease progresses (Hughes, 1963b; Pearson and others, 1964) (Walton, 1964 (1963) claim that activities of as much as 500 times the upper limit of normal are encountered. Recently the author has observed a value of 17000 I.U./1. in a case of dermatomyositis which following steroid therapy fell to 28.5 units, i.e., well within normal limits (Table 1) ; and in a chronic case with a 4-year history who improved on treatment the enzyme level fell from just above normal limits in the pre-treatment period to a level again well within normal limits afterwards. Fowler and Pearson (1964) have presented data on successive serum phosphocreatine kinase estimations during the course of treatment and showed a progressive fall to normal limits. Pearson (1964) (Thompson and Vignos, 1959; Gautier and Richterich, 1963) (Pearson, 1964) .
Thyroid disease
Various workers (e.g. Griffiths, 1963; Saito, Hibi, Kawazura and Fukuyama, 1963) have reported that serum phosphocreatine kinase is frequently elevated in hypothyroidism and returns to normal following replacement therapy (Saito and others, 1963 Schapira, Dreyfus, Schapira and Demos (1960) found that both aldolase and phosphocreatine kinase was raised in a proportion of the mothers of children with the sex-linked form and that raised values were found more often in cases where the family history was positive. Leyburn, Thomson and Walton (1961) , however, were unable to detect any serum aldolase abnormalities in known and possible carriers.
Later work (e.g. Hughes, 1962 Hughes, , 1963a Barwick, 1963; Richterich and others, 1963) confirmed the observation of Schapira and others (1960) (Emery, 1963; Pearson, Fowler and Wright, 1963) and that occasionally clinical signs may be present (Emery, 1963 ). An explanation of these findings (Emery, 1964a; Pearson and others, 1963) has been suggested on the basis of the so-called Lyon hypothesis (Lyon, 1961) (Thompson and Vignos, 1959) , although it is possible that outflow is also reduced when physical activity becomes restricted (Thomson, 1962) and that this is an additional factor.
Two general questions may be asked, firstly is the loss of tissue enzymes a major cause of degeneration, and, secondly, does the increased permeability of the cell membrane denote that the membrane is the site of the primary, genetically determined defect? Pennington (1964) 
